Experimental and Molecular Medicine (Feb 2019)

PAK4 signaling in health and disease: defining the PAK4–CREB axis

  • So-Yoon Won,
  • Jung-Jin Park,
  • Eun-Young Shin,
  • Eung-Gook Kim

DOI
https://doi.org/10.1038/s12276-018-0204-0
Journal volume & issue
Vol. 51, no. 2
pp. 1 – 9

Abstract

Read online

Gene expression: The role of a regulatory enzyme in disease An enzyme that regulates an important controller of gene expression may offer a therapeutic target for cancer and other diseases. cAMP response element-binding protein (CREB) interacts with various other proteins to switch a myriad of target genes on and off in different cells. A review by Eung-Gook Kim, Eun-Young Shin and colleagues at Chungbuk National University, Cheongju, South Korea, explores the interplay between CREB and an enzyme called p21-activated kinase 4 (PAK4) in human health and disease. PAK4, for example, has been shown to promote CREB’s gene-activating function in prostate cancer, and PAK4 overexpression is a feature of numerous other tumor types. Disruptions in PAK4-mediated regulation of CREB activity have also been observed in neurons affected by Parkinson’s disease. The authors see strong clinical promise in further exploring the biology of the PAK4-CREB pathway.